- 1) Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M., and Kader, A. A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem., 48, 4581–4589 (2000).
- 2) Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., and Fuhrman, B., Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr., 71, 1062–1076 (2000).
- 3) Wang, R. F., Xie, W. D., Zhang, Z., Xing, D. M., Ding, Y., Wang, W., Ma, C., and Du, L. J., Bioactive compounds from the seeds of Punica granatum (pomegranate). J. Nat. Prod., 67, 2096–2098 (2004).
- 4) Singh, R. P., Chidambara, Murthy, K. N., and Jayaprakasha, G. K., Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. J. Agric. Food Chem., 50, 81–86 (2002).
- 5) Kaplan, M., Hayek, T., Raz, A., Coleman, R., Dornfeld, L., Vaya, J., and Aviram, M., Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J. Nutr., 131, 2082–2089 (2001).
- 6) Moneam, N. M., el Sharaky, A. S., and Badreldin, M. M., Oestrogen content of pomegranate seeds. J. Chromatogr., 438, 438–442 (1988).
- 7) Du, C. T., Wang, P. L., and Fransis, F. J., Anthocyanins of pomegranate, Punica granatum. J. Food Sci., 40, 417–418 (1975).
- 8) Tanaka, T., Nonaka, G., and Nishioka, I., Tannins and related compounds. XLI. Isolation and characterization of novel ellagitannnins, punicacorteins A, B, C and D, and punigluconin from the bark of Punica granatum L. Chem. Pharm. Bull., 34, 656–663 (1986).
- 9) Mukhtar, H., Das, M., and Bickers, D. R., Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res., 46, 2262–2265 (1986).
- 10) Mass, J. L., Galletta, G. J., and Stoner, G. D., Ellagic acid, an anticarcinogen in fruits, especially in strawberries. HortScience, 26, 10–14 (1991).
- 11) Thresiamma, K. C., and Kuttan, R., Inhibition of liver fibrosis by ellagic acid. Indian J. Physiol. Pharmacol., 40, 363–366 (1996).
- 12) Osawa, T., Ide, A., Su, J. D., and Namiki, M., Inhibition of lipid peroxidation by ellagic acid. J. Agric. Food Chem., 35, 808–812 (1987).
- 13) Shimogaki, H., Tanaka, Y., Tamai, H., and Masuda, M., In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition. Int. J. Cosmet. Sci., 22, 291–303 (2000).
- 14) Lee, S. H., Choi, S. Y., Kim, H., Hwang, J. S., Lee, B. G., Gao, J. J., and Kim, S. Y., Mulberroside F isolated from the leaves of Morus alba inhibits melanin biosynthesis. Biol. Pharm. Bull., 25, 1045–1048 (2002).
- 15) Staricco, R. J., and Pinkus, H., Quantitative and qualitative data on the pigment cells of adult human epidermis. J. Invest. Dermatol., 28, 33–45 (1957).
- 16) Hearing, V. J., and Tsukamoto, K., Enzymatic control of pigmentation in mammals. FASEB J., 5, 2902–2909 (1991).
- 17) Yamakoshi, J., Otsuka, F., Sano, A., Tokutake, S., Saito, M., Kikuchi, M., and Kubota, Y., Lightening effect on ultraviolet-induced pigmentation of guinea pig skin by oral administration of a proanthocyanidin-rich extract from grape seeds. Pigment. Cell Res., 16, 629–638 (2003).
- 18) Funayama, M., Arakawa, H., Yamamoto, R., Nishino, T., Shin, T., and Murao, S., Effects of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Biosci. Biotechnol. Biochem., 59, 143–144 (1995).
- 19) Doyle, B., and Griffiths, L. A., The metabolism of ellagic acid in the rat. Xenobiotica, 10, 247–256 (1980).
- 20) Quevedo, Jr. W. C., Holstein, T. J., Dyckman, J., McDonald, C. J., and Isaacson, E. L., Inhibition of UVR-induced tanning and immunosuppression by topical applications of vitamins C and E to the skin of hairless (hr/hr) mice. Pigment. Cell Res., 13, 89–98 (2000).
- 21) Beehler, B. C., Przybyszewski, J., Box, H. B., and Kulesz-Martin, M. F., Formation of 8-hydroxydeoxy-guanosine within DNA of mouse keratinocytes exposed in culture to UVB and H2O2. Carcinogenesis, 13, 2003–2007 (1992).
- 22) Lee, J. H., An, H. T., Chung, J. H., Kim, K. H., Eun, H. C., and Cho, K. H., Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes. Photodermatol. Photoimmunol. Photomed., 18, 253–261 (2002).
- 23) Ashoori, F., Suzuki, S., Zhou, J. H., Isshiki, N., and Miyachi, Y., Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plast. Reconstr. Surg., 94, 1027–1037 (1994).
- 24) Tomita, Y., Hariu, A., Mizuno, C., and Seiji, M., Inactivation of tyrosinase by dopa. J. Invest. Dermatol., 75, 379–382 (1980).
- 25) Fujiwara, Y., Sahashi, Y., Aritro, M., Hasegawa, S., Akimoto, K., Ninomiya, S., Sakaguchi, Y., and Seyama, Y., Effect of simultaneous administration of vitamin C, L-cysteine and vitamin E on the melanogenesis. Biofactors, 21, 415–418 (2004).
- 26) Lei, F., Xing, D. M., Xiang, L., Zhao, Y. N., Wang, W., Zhang, L. J., and Du, L. J., Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 796, 189–194 (2003).
Bioscience, Biotechnology, and Biochemistry
Volume 69, 2005 - Issue 12